Allogene Therapeutics ALLO Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's earnings yield?
- Allogene Therapeutics (ALLO) reported earnings yield of -29.2% in Q1 2026.
- How has Allogene Therapeutics's earnings yield changed year-over-year?
- Allogene Therapeutics's earnings yield increased by 63.3% year-over-year, from -79.5% to -29.2%.
- What is the long-term trend for Allogene Therapeutics's earnings yield?
- Over 5 years (2020 to 2025), Allogene Therapeutics's earnings yield has grown at a 47.8% compound annual growth rate (CAGR), from -8.8% to -62%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.